Company registration number SC209292 (Scotland)
JOHN ROSS (CHEMISTS) LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
JOHN ROSS (CHEMISTS) LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 8
JOHN ROSS (CHEMISTS) LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
710,059
774,384
Investment property
5
305,000
305,000
Investments
6
4,833
4,833
1,019,892
1,084,217
Current assets
Stocks
7
283,985
279,624
Debtors
8
2,032,396
2,147,510
Cash at bank and in hand
844
31,246
2,317,225
2,458,380
Creditors: amounts falling due within one year
9
(1,243,916)
(1,218,749)
Net current assets
1,073,309
1,239,631
Total assets less current liabilities
2,093,201
2,323,848
Creditors: amounts falling due after more than one year
10
(46,100)
(63,641)
Provisions for liabilities
(4,967)
(13,575)
Net assets
2,042,134
2,246,632
Capital and reserves
Called up share capital
100
100
Other reserve
98,016
98,016
Profit and loss reserves
1,944,018
2,148,516
Total equity
2,042,134
2,246,632
JOHN ROSS (CHEMISTS) LIMITED
BALANCE SHEET (CONTINUED)
AS AT
30 NOVEMBER 2025
30 November 2025
- 2 -
For the financial year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 27 August 2026 and are signed on its behalf by:
J ROSS
Mr J Ross
Director
Company registration number SC209292 (Scotland)
JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 3 -
1
Accounting policies
Company information
John Ross (Chemists) Limited is a private company limited by shares incorporated in Scotland. The registered office is 28 Albyn Place, Aberdeen, United Kingdom, AB10 1YL.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Revenue
Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.
When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.4
Intangible fixed assets - goodwill
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.
For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.
1.5
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 4 -
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold property
2% Straight line
Improvements
2% Straight line
Fixtures and fittings
20% Straight line
Motor vehicles
25% Straight line
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.6
Investment property
Investment property, which is property held to earn rentals and/or for capital appreciation, is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at the reporting end date. Investment property is carried at fair value determined annually by the directors and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided. Changes in fair value are recognised in the Statement of comprehensive income.
1.7
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.8
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.9
Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors and loans from group companies. These are measured at amortised cost and are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of comprehensive income.
1.10
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
1
Accounting policies
(Continued)
- 5 -
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
1.11
Retirement benefits
The company operates a defined contribution plan for it's employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payment obligations. The contributions are recognised as an expense in the Statement of comprehensive income when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the company in independently administered funds.
1.12
Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.
A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
1.13
Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
37
47
JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 6 -
3
Intangible fixed assets
Goodwill
£
Cost
At 1 December 2024
1,920,501
Transfers
(77,825)
At 30 November 2025
1,842,676
Amortisation and impairment
At 1 December 2024
1,920,501
Transfers
(77,825)
At 30 November 2025
1,842,676
Carrying amount
At 30 November 2025
At 30 November 2024
4
Tangible fixed assets
Freehold property
Improvements
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 December 2024
629,235
184,474
551,797
391,604
1,757,110
Additions
11,634
11,634
Disposals
(45,909)
(45,909)
Transfers
(41,463)
(41,463)
At 30 November 2025
629,235
184,474
521,968
345,695
1,681,372
Depreciation and impairment
At 1 December 2024
151,504
56,776
526,049
248,397
982,726
Depreciation charged in the year
11,444
3,689
8,253
49,056
72,442
Eliminated in respect of disposals
(45,909)
(45,909)
Transfers
64
(64)
(37,946)
(37,946)
At 30 November 2025
163,012
60,401
496,356
251,544
971,313
Carrying amount
At 30 November 2025
466,223
124,073
25,612
94,151
710,059
At 30 November 2024
477,731
127,698
25,748
143,207
774,384
JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 7 -
5
Investment property
2025
£
Fair value
At 1 December 2024 and 30 November 2025
305,000
The directors have considered the value of the investment properties and in their opinion, the properties are disclosed in the Balance Sheet at their open market values.
6
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
3
3
Other investments other than loans
4,830
4,830
4,833
4,833
7
Stocks
2025
2024
£
£
Stocks
283,985
279,624
8
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
392,110
414,206
Other debtors
1,520,264
1,606,712
Prepayments and accrued income
19,157
20,754
1,931,531
2,041,672
2025
2024
Amounts falling due after more than one year:
£
£
Other debtors
100,865
105,838
Total debtors
2,032,396
2,147,510
JOHN ROSS (CHEMISTS) LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 NOVEMBER 2025
- 8 -
9
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
543,948
383,458
Obligations under finance leases
10,980
28,304
Other borrowings
14,441
Trade creditors
494,517
634,985
Corporation tax
32,371
8,340
Other taxation and social security
19,834
36,285
Other creditors
2,883
3,302
Accruals and deferred income
124,942
124,075
1,243,916
1,218,749
10
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
46,100
63,641
The loan is secured by a means of a fixed and floating charge over all assets of the company.
11
Related party transactions
Transactions
During the year the company made advances to one of the directors of £119,589. Credits were received of £304,306. At the balance sheet date, the balance owed to the company was £113,031 (2024 - £297,748). The loan is unsecured and interest free with no fixed repayment terms in place.
During the year the company also operated a loan account with a company which is owned by one of the directors. £93,455 was advanced during the year and credits of £27,094 were received. At the balance sheet date, the balance owed to the company was £834,127 (2024 - £767,766).
During the year the company also operated a loan account with another company which is owned by one of the directors. £20,634 was advanced during the year and credits of £26,715 were received. At the balance sheet date, the balance owed to the company was £470,090 (2024 - £476,171).
The company has taken advantage of the exemption within FRS102 section 1AC.35 (Related Party Disclosure) which allows exemption from disclosure of related party transactions with other group companies.true